Thiazolyl amide derivatives
AssigneeBayer Aktiengesellschaft
InventorsRudiger Fischer, Gerald Kleymann, Ulrich Betz, Judith Baumeister, Wolfgang Bender, Peter Eckenberg, Gabriele Handke, Martin Hendrix, Kerstin Henninger, Axel Jensen, Jorg Keldenich, Udo Schneider, Olaf Weber
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel compounds, to a process for their preparation and to their use as medicaments, in particular as antiviral medicaments.
Claims27
Compounds of the general formula (I):
- 183
- in which
- R1 represents hydrogen, halogen, (C1-C6)-alkyl, (C1-C6)-alkoxy, amino-(C1-C6)-alkyl or halogeno-(C1-C6)alkyl,
- R2 and R3 are identical or different and represent hydrogen, (C1-C6)alkoxy, (C3-C8)cycloalkyl or biphenylaminocarbonyl, or
- represent (C1-C6)-alkyl which is optionally substituted by 1 to 3 substituents selected from the group consisting of (C3-C6)-cycloalkyl, (C1-C6)-alkoxy, halogen, hydroxyl, amino, tri-(C1-C6)-alkylsilyloxy, radicals of the formula
- 184
- in which R2′ represents hydrogen or (C1-C4)-alkyl,
- a 5- or 6-membered aromatic heterocycle having up to 3 heteroatoms from the group consisting of S, N and O, where a nitrogen-containing heterocycle may also be attached via the nitrogen atom,
- a 3- to 8-membered saturated or unsaturated nonaromatic heterocycle having up to 3 heteroatoms from the group consisting of S, N and O, which may optionally be attached via a nitrogen atom, and
- (C6-C10)-aryl which for its part may be substituted by hydroxyl or (C1-C6)-alkoxy, or
- represent a group of the formula
- 185
- in which R8 and R9 are identical to or different from one another and represent hydrogen and (C1-C4)-alkyl, or
- represent a group of the formula
- 186
- in which R10 is the side-group of a naturally occurring α-amino acid, or
- represent a group of the formula
- 187
- in which R11 represents (C1-C4)-alkyl and R12 represents hydrogen, (C1-C4)-alkyl or represents a group of the formula
- 188
- in which R10′ is the side-group of a naturally occurring α-amino acid, or
- R2 and R3 together with the nitrogen atom form a 5- or 6-membered saturated heterocycle which may optionally contain an oxygen atom,
- R4 represents hydrogen, (C1-C6)-acyl, (C2-C6)-alkenyl, (C3-C8)-cycloalkyl, or
- R4 represents (C1-C6)-alkyl which may optionally be substituted by 1 to 3 substituents selected from the group consisting of halogen, hydroxyl, (C3-C8)-cycloalkyl, (C1-C6)-acyl, (C1-C6)-alkoxy, carboxyl,
- 189
- in which R4 represents hydrogen, —(OCH2CH2),OCH2CH3, in which n is 0 or 1, phenoxy, (C6-C10)-aryl and —NR3R14,
- in which R13 and R14 are identical or different and represent hydrogen, (C1-C6)-acyl, (C1-C6)-alkyl, carbamoyl, mono- or di-(C1-C6)-alkylamino-(C1-C6)-alkyl, mono- or di-(C1-C6)-alkylaminocarbonyl, (C6-C10)-aryl or (C1-C6)-alkoxycarbonyl, or
- R13 and R14 together with the nitrogen atom form a 5- or 6-membered saturated heterocycle which may optionally contain a further heteroatom from the group consisting of S and O or a radical of the formula —NR15, and which may be substituted by oxo,
- in which
- R15 represents hydrogen or (C1-C4)-alkyl, or
- R4 represents (C1-C6)-alkyl which is substituted by a 5- or 6-membered aromatic, optionally benzo-fused heterocycle having up to 3 heteroatoms from the group consisting of S, N and O, where a nitrogen-containing heterocycle may also be attached via the nitrogen atom, or which is substituted by
- radicals of the formulae
- 190
- in which
- R16 represents hydrogen or (C1-C6)-alkyl,
- R17 and R18 are identical or different and represent hydrogen, (C1-C6)alkyl or (C6-C10)-aryl, where abovementioned (C1-C6)-alkyl and (C6-C10)-aryl may optionally be substituted by 1 to 3 substituents selected from the group consisting of hydroxyl, (C1-C6)-alkoxy and halogen,
- R5 represents hydrogen, (C1-C6)-alkyl, halogen, amino, mono- or di-(C1-C6)-alkylamino or represents (C1-C6)-alkanoylamino,
- R6 represents phenyl which may optionally be substituted by one to three substituents selected from the group consisting of
- halogen,
- (C6-C10)-aryl which may optionally be substituted by 1 to 3 substituents selected from the group consisting of (C1-C6)-alkanoyl, (C1-C6)-alkoxy, (C1-C6)-alkyl, halogen, (C1-C6)-alkoxycarbonyl, nitro, halogeno-(C1-C6)-alkyl, halogeno-(C1-C6)-alkoxy, amino, (C1-C6)-alkylthio, hydroxyl, carboxyl, carbamoyl, mono- or di-(C1-C6)-alkylaminocarbonyl, mono- or di-(C1-C6)-alkanoylamino, (C1-C6)-alkoxycarbonylamino, (C1-C6)-alkylsulphoxy, (C1-C6)-alkylsulphonyl, tri-(C1-C6)-alkylsilyloxy, a 3- to 8-membered saturated or unsaturated nonaromatic mono- or bicyclic heterocycle having up to 3 heteroatoms from the group consisting of S, N and O, which may optionally be attached via a nitrogen atom, and/or cyano,
- (C1-C6)-alkoxy,
- (C1-C6)-alkoxycarbonyl,
- (C1-C6)-alkylthio,
- hydroxyl,
- carboxyl,
- partially fluorinated (C1-C6)-alkoxy having up to 6 fluorine atoms,
- (C1-C6)-alkyl which is optionally substituted by a radical of the formula
- 191
- a 5- or 6-membered aromatic heterocycle having up to 3 heteroatoms from the group consisting of S, N and O which may optionally be attached via a nitrogen atom and which may optionally be substituted by 1 to 3 substituents selected from the group consisting of (C1-C6)-alkanoyl, (C1-C6)-alkoxy, (C1-C6)-alkyl, halogen, (C1-C6)-alkoxycarbonyl, nitro, halogeno-(C1-C6)-alkyl, halogeno-(C1-C6)-alkoxy, amino, (C1-C6)-alkylthio, hydroxyl, carboxyl, carbamoyl, aminocarbonyl, mono- or di-(C1-C6)-alkylaminocarbonyl, mono- or di-(C1-C6)-alkanoylamino, (C1-C6)-alkoxycarbonylamino, (C1-C6)-alkylsulphoxy, (C1-C6)-alkylsuphonyl, a 3- to 8-membered saturated or unsaturated nonaromatic mono- or bicyclic heterocycle having up to 3 heteroatoms from the group consisting of S, N and O which may optionally be attached via a nitrogen atom, and/or cyano,
- a 3- to 8-membered saturated or unsaturated nonaromatic mono- or bicyclic heterocycle having up to 3 heteroatoms from the group consisting of S, N and O, which may optionally be attached via a nitrogen atom and which may optionally be substituted by 1 to 3 substituents selected from the group consisting of oxo, halogen, hydroxyl, (C1-C6)-alkoxycarbonyl, (C1-C6)-alkoxycarbonylamino, (C1-C6)-alkyl, halogeno-(C1-C6)-alkyl and hydroxy-(C1-C6)-alkyl,
- (C2-C6)-alkenyl
- and groups of the formulae
- —OR19,
- —NR20R21 or —CO—NR22R23,
- carbazole, dibenzofuran or dibenzothiophene,
- xanthene or 9,10-dihydroacridine,
- in which R19 is phenyl which for its part is optionally substituted by a group of the formula —NR24R25
- in which
- R24 and R25 are identical or different and represent hydrogen, (C1-C6)-alkyl or (C1-C6)-acyl, or
- R19 represents (C1-C6)-alkyl which is optionally mono- to trisubstituted by hydroxyl and/or halogen,
- R20 and R21 are identical or different and represent hydrogen, carbamoyl, mono- or di-(C1-C6)-alkylaminocarbonyl, phenyl, (C1-C6)-acyl or (C1-C6)-alkyl,
- where abovementioned (C1-C6)-alkyl is optionally substituted by (C1-C6)-alkoxy, (C1-C6)-acyl, by phenyl or by a 5- or 6-membered aromatic heterocycle having up to 3 heteroatoms from the group consisting of S, N and O,
- where abovementioned phenyl and abovementioned aromatic heterocycle are optionally mono- to trisubstituted by identical or different substituents from the group consisting of halogen and hydroxyl, and
- R22 and R23 are identical or different and represent hydrogen or (C1-C6)-alkyl,
- and R7 may have the meaning of R5 and may be identical to or different from R5,
- and their salts.
Use of N-[5-(aminosulphonyl)-1,3-thiazol-2-yl]acetamide derivatives for preparing medicaments.
Use of N-[5-(aminosulphonyl)-1,3-thiazol-2-yl]-2-phenylacetamide derivatives for preparing medicaments.
Use of N-[5-(aminosulphonyl)-1,3-thiazol-2-yl]-2-[1,1′-biphenyl]-4-ylacetamide derivatives for preparing medicaments.
Dependencies are inferred from the claim text.